2011
DOI: 10.1136/jmg.2011.088807
|View full text |Cite
|
Sign up to set email alerts
|

Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features

Abstract: The mutation frequency in patients meeting CS diagnostic criteria (34%) was significantly lower than previously reported, suggesting a need for reevaluation of these criteria. A mutation prediction model has been developed which can help identify patients appropriate for PTEN testing in clinical practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
111
0
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 141 publications
(113 citation statements)
references
References 34 publications
1
111
0
1
Order By: Relevance
“…[24][25][26][27][28] Clinical diagnostic criteria involve combinations of major and minor criteria 29 ( Table 4). We recommend referral for anyone meeting any three criteria from the major or minor diagnostic criteria.…”
Section: Cowden Syndrome Also Known As Pten Hamartoma Tumor Syndromementioning
confidence: 99%
“…[24][25][26][27][28] Clinical diagnostic criteria involve combinations of major and minor criteria 29 ( Table 4). We recommend referral for anyone meeting any three criteria from the major or minor diagnostic criteria.…”
Section: Cowden Syndrome Also Known As Pten Hamartoma Tumor Syndromementioning
confidence: 99%
“…Patients with Cowden syndrome also have an increased risk of breast, endometrial, thyroid, kidney, and colorectal cancers. [8] In Bannayan-Riley-Ruvalcaba syndrome, in addition to hamartomas, patients exhibit multiple subcutaneous lipomas and macrocephaly. Genitourinary manifestations include penile lentigines (pigmented macules).…”
Section: Discussionmentioning
confidence: 99%
“…Gastrointestinal polyps, also typically found in CS, are usually asymptomatic and can occur anywhere in the tract, but mostly at the colon (13,14). Cowden syndrome patients are at increased risk of developing breast, thyroid, and endometrium cancer.…”
Section: Discussionmentioning
confidence: 99%
“…PTEN hamar toma tumor syndromes are inherited in an autosomal dominant manner across all subtypes. PTEN is a tumor suppressor gene with dual speci ficity phosphatase activity, and the Nterminal domain contains the phosphatase domain active site, where most PTEN mutations occur (13). PTEN negatively regulates the phosphatidylinositol 3kinaseAKT and mammalian target of rapamycin (mTOR) signalling pathways, which are critical for cell proliferation, cell cycle progression, and apoptosis.…”
Section: Discussionmentioning
confidence: 99%